AD Luber

Publications

Citations

H-Index

2007

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

AD Luber is an author at GlaxoSmithKline (United States) specializing in antimicrobial pharmacokinetics, antimicrobial pharmacodynamics, and medicine.

Top concepts

MedicinePharmacologyDrug AnalysisDrug MonitoringPharmacotherapyPharmacokineticsClinical PharmacologyMolecular PharmacologyPharmacokinetic ModelingQuantitative Pharmacology

Publications per year

2007–2009

Publications

Steady‐state pharmacokinetics of once‐daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers<sup>*</sup>

AD Luber, Ronald W. Brower, D Kim et al. · HIV Medicine · 2007 · 34 citations

Steady‐state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir‐boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers

AD Luber, D V Condoluci, PD Slowinski et al. · HIV Medicine · 2009 · 10 citations

Steady‐state Amprenavir, Tdf 300, Quantitative Pharmacology +16

Rows per page

1–2 of 2